Skip to main content

Advertisement

Table 2 Secondary analysis of three longitudinal studies reporting distress prevalence in the follow-up period

From: Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis

        Baseline Follow-up Comparison
First author Year Country Study design When distress assessed initially Distress cut-off Follow-up No. of patients with Distress, n Total number of Patients assessed, n Prevalence of Distress,%(95% Cl) No. of patients with Distress, n Total number of Patients assessed, n Prevalence of Distress,%(95% Cl) Relative Increase Ratio,%(95% Cl)
Rooney 2012 UK longitudinal during primary radiotherapy DT ≥ 4 3 mo 19 155 12.3 (7.1–17.4) 15 108 13.9 (7.4–20.4) 0.81 (0.42,1.54)
Trad 2015 Australia longitudinal newly diagnosis or first recurrence DT ≥ 4 3 mo 36 96 37.5 (27.8–47.2) 9 12 75.0 (50.5–99.5) 1.57 (0.89,2.77)
Rooney 2013 UK longitudinal shortly after starting chemo/radiotherapy DT ≥ 4 3 mo 56 154 36.4 (28.8–44.0) 37 103 35.9 (26.7–45.2) 0.99 (0.78,1.35)
  1. DT Distress Thermometer, CI confidence interval